March 12 , 2008
Proteon Therapeutics appoints Gregory D. Phelps, a seasoned biopharmaceutical executive, to the Company's Board of Directors.
Download article (pdf)
March 12, 2008
Proteon Therapeutics, Inc., announced today that a key patent has been issued by the European Patent Office.
Download article (pdf)
November 1, 2007
Proteon Therapeutics to Present at Annual Meeting of American Society of Nephrology in San Francisco on November 2, 2007
Download article (pdf)
September 6, 2007
Proteon Therapeutics completes $12 million financing and hires CFO
Download article (pdf)
January 23, 2007
Proteon Therapeutics receives second issued U.S. patent broadly covering elastase vasodilation
Download article (pdf)
September 12, 2006
Proteon Therapeutics adds experienced research and drug development talent to its team
Download article (pdf)
August 28, 2006
EDC of Kansas City announces creation of “Kansas City Biotechnology Center”
Download article (pdf)
June 26, 2006
Proteon Therapeutics receives issued U.S. patent broadly covering new method of artery and vein dilation
Download article (pdf)
June 21, 2006
Proteon Therapeutics selects QSV Biologicals, Ltd for PRT-201 manufacturing
Download article (pdf)
May 10, 2006
Proteon Therapeutics hires veteran biotechnology executive Timothy Noyes as CEO
Download article (pdf)
March 29, 2006
Proteon Therapeutics, Inc. closes $19M in Series A financing
Download article (pdf)
January 13, 2006
Proteon Therapeutics, LLC and The University of Kansas Medical Center present at the annual meeting of the American Society of Nephrology
Download article (pdf)
January 13, 2006
Proteon Therapeutics, LLC closes $927,000 round of angel financing
Download article (pdf)
January 12, 2005
Proteon Therapeutics, LLC awarded grant by National Institutes of Health for new cardiovascular drug development program
Download article (pdf)
July 23, 2004
Proteon Therapeutics, LLC announces award of STTR grant
Download article (pdf)
June 22, 2004
Proteon Therapeutics, LLC research labs to locate in the Biotechnology Development Center of Greater Kansas City
Download article (pdf)
Headlines
Proteon Therapeutics completes $12 million financing and hires CFO
Proteon Therapeutics receives second issued U.S. patent broadly covering elastase vasodilation
Proteon Therapeutics adds experienced research and drug development talent to its team
EDC of Kansas City announces creation of “Kansas City Biotechnology Center”
Proteon Therapeutics selects QSV Biologicals, Ltd for PRT-201 manufacturing
Proteon Therapeutics hires veteran biotechnology executive as CEO
Proteon Therapeutics, Inc. closes $19M in Series A financing
